Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7.
Article Details
- CitationCopy to clipboard
Kao HH, Chang MS, Cheng JF, Huang JD
Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7.
J Biomed Sci. 2003 Jan-Feb;10(1):98-110.
- PubMed ID
- 12566991 [ View in PubMed]
- Abstract
The multidrug resistance-associated protein (MRP) subfamily transporters associated with anticancer drug efflux are attributed to the multidrug-resistance of cancer cells. The genomic organization of human multidrug resistance-associated protein 7 (MRP7) was identified. The human MRP7 gene, consisting of 22 exons and 21 introns, greatly differs from other members of the human MRP subfamily. A splicing variant of human MRP7, MRP7A, expressed in most human tissues, was also characterized. The 1.93-kb promoter region of MRP7 was isolated and shown to support luciferase activity at a level 4- to 5-fold greater than that of the SV40 promoter. Basal MRP7 gene expression was regulated by 2 regions in the 5'-flanking region at -1,780-1,287 bp, and at -611 to -208 bp. In Madin-Darby canine kidney (MDCK) cells, MRP7 promoter activity was increased by 226% by genotoxic 2-acetylaminofluorene and 347% by the histone deacetylase inhibitor, trichostatin A. The protein was expressed in the membrane fraction of transfected MDCK cells.